Physician profile
Zane A Darnell
NPI 1356330732
$2,274.51
in general payments reported to CMS, 2019-2025
21 companies · $160 in 2025
The $160 reported for 2025 was less than what a typical Cardiovascular Disease provider received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $209 · 2020: $360 · 2021: $908 · 2022: $286 · 2023: $187 · 2024: $165 · 2025: $160.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $511.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $511.38 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $1,347.10 | 2020-2025 | Cardiomems, Assurity, Confirm Rx |
| Novartis Pharmaceuticals Corporation | $211.89 | 2019-2025 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $187.20 | 2019-2025 | Lifevest |
| E.R. Squibb & Sons, L.L.C. | $52.53 | 2019-2022 | |
| Janssen Pharmaceuticals, INC | $52.01 | 2021 | |
| Pfizer INC. | $47.58 | 2022-2025 | |
| Medtronic Vascular, INC. | $47.51 | 2019-2020 | |
| Merck Sharp & Dohme LLC | $43.38 | 2022-2025 | Verquvo |
| Amgen INC. | $34.70 | 2022-2023 | Repatha |
| Boehringer Ingelheim Pharmaceuticals, INC. | $26.23 | 2021-2022 | |
| Inspire Medical Systems, INC. | $24.87 | 2025 | Inspire |
| Atricure, INC. | $24.58 | 2024 | |
| Astrazeneca Pharmaceuticals LP | $24.45 | 2019 | |
| Acist Medical Systems, INC. | $24.00 | 2022 | |
| Novo Nordisk INC | $23.22 | 2024 | Ozempic |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Cardiva Medical, INC. | $20.63 | 2024 | Cardiva Vascade Mvp Vvcs 6-12f |
| Boston Scientific Corporation | $20.24 | 2024 | Watchman Access System |
| Sanofi-Aventis U.S. LLC | $18.57 | 2019 | |
| Esperion Therapeutics, INC. | $16.74 | 2021 | |
| Bayer Healthcare Pharmaceuticals INC. | $13.57 | 2025 | |
| Philips North America LLC | $13.51 | 2023 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Zane Darnell listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.